Many vertebral axial decompression
studies available today were done on a table called “VAX-D”. It’s a great unit, and the same technology
was used to make the Triton DTS instead because (in our opinion) it is more comfortable for the patient, and the results are
at least as good. Since the VAX-D has been around longer, most independent studies utilized (or utilize) this table. The following
is a list of some of the research using the VAX-D.
Journal of Orthopedic & Sports Physical Therapy (Vol.35, No.1, January 2005)
and Long-term Outcomes Following Treatment with the Vax-D protocol for Patients with Chronic, Activity-limiting Low Back Pain.
OUTCOME: Significant improvements in a sample of patients with unfavorable prognosis due to chronic
low back pain.
Journal of Neurologic Research (Vol. 29, No. 3, March 2003)
Efficacy of Vertebral
Axial Decompression on Chronic Low Back Pain.
OUTCOME: This 144 patient study showed 76% achieved remission of pain. Except
in emergent conditions, VaxX-D should be used on all conditions before surgery is undertaken.
News, (Vol. 29, No. 3, March 2003)
Vax-D Reduces Chronic Discogenic Lo Back Pain-4 Year Study.
OUTCOME: Four year follow-up after Vax-D treatment shows a sustained 86% reduction in pain and that 91% of patients
had resumed their normal activities.
Neurological Research Journal (Vol. 23, p. 706-714, October 2001)
Somatosensory Evoked Potential Demonstration of Nerve Root Decompression after Vax-D Therapy.
Pain reduction in the study group was 77% with successful decompression of the nerve roots at multiple levels.
Neurological Research Journal (Vol. 23, p. 780-784, October 2001)
A Prospective Randomized Controlled Study
of Vax-D and Tens for the Treatment of Chronic Low Back Pain.
OUTCOME: A statistically significant reduction
in pain and improvement in functional outcome was obtained in patients with chronic low back pain treated with Vax-D.
Canadian Journal of Clinical Medicine (Vol. 6, No. 1, January 1999)
An Overview of Vertebral
Axial Decompression by Frank Tilaro, M.D.
OUTCOME: Vax-D is significantly capable of influencing sensory nerve function
associated with a compressive radiculopathy. Complete remission was achieved by 64% of the study group.
Canadian Journal of Clinical Medicine (Vol. 5, No.1, January 1998)
The effects of Vax-D on sensory nerve
function in Patients with Low Back Pain and Radiculopathy.
OUTCOME: The average pain reduction was 77%
Journal of Neurological Research (Vol. 20, No. 3, April 1998)
Vertebral Axial Decompression Therapy for Pain Associated with
Herniated or Degenerative Discs or Facet Syndrome: An outcome Study of 778 Cases.
OUTCOME: The authors
consider Vax-D to be a primary modality for low back pain, lumbar herniations at single and multiple levels, degenerative
discs, and facet arthropathy, and decreased spinal mobility.
Journal of Neurosurgery (Vol.
81: 350-353, 1994)
Effects of Vertebral Axial Decompression on Intradiscal Pressure.OUTCOME: Proof that Vax-D creates
a negative intradiscal pressure force up to –160mmhg.